Related Experiment Video
Updated: Oct 1, 2025

09:20
Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
6.7K
Is there a latent left ventricular dysfunction in hypertensive patients with preserved ejection fraction?
La Tunisie Medicale
|March 4, 2022
Summary
Early detection of left ventricular dysfunction in hypertension is crucial. Global Longitudinal Strain (GLS) is a sensitive biomarker for subclinical myocardial impairment in hypertensive patients, enabling earlier intervention.
Area of Science:
- Cardiology
- Echocardiography
- Hypertension Research
Background:
- Early detection of left ventricular (LV) dysfunction is vital for reducing cardiovascular morbidity and mortality.
- Hypertension is a major risk factor for developing LV dysfunction.
- Preserved ejection fraction (EF) can mask underlying systolic impairment.
Purpose of the Study:
- To evaluate longitudinal contractility in patients with essential hypertension and preserved LV ejection fraction (EF).
- To detect latent impairment of LV systolic function using advanced echocardiographic techniques.
Main Methods:
- Prospective case-control study involving 121 hypertensive patients and 39 healthy controls.
- Utilized conventional echocardiography and 2D-speckle tracking echocardiography (2D-STE) for imaging.
- Assessed global longitudinal strain (GLS) and diastolic function parameters.
Main Results:
- Hypertensive patients showed increased septal thickness, LV mass, and left atrium volume compared to controls.
- Global Longitudinal Strain (GLS) was significantly reduced in hypertensive patients (-17.69 ± 4.06%) versus controls (-22.70 ± 5.02%).
- A decrease in GLS was more pronounced in hypertensive patients with left ventricular hypertrophy.
Conclusions:
- Global Longitudinal Strain (GLS) is a sensitive biomarker for subclinical myocardial dysfunction in hypertensive patients.
- Identifying patients with impaired GLS can facilitate earlier intervention strategies.
- This approach may help mitigate the risk of heart failure in hypertensive individuals.
Related Concept Videos
Heart Failure II: Pathophysiology
85
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
85
Pathophysiology of Heart Failure
1.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
78
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
78
Mitral Regurgitation I: Introduction
76
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
76
Heart Failure III: Clinical Manifestations
69
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
69
Mitral Stenosis I: Introduction
68
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
68

